These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8953584)

  • 21. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio in melanoma: A marker of variation in surgical quality?
    Spillane AJ; Winstanley J; Thompson JF
    Cancer; 2009 Jun; 115(11):2384-7. PubMed ID: 19306419
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymph node assessment in melanoma.
    Easson AM; Rotstein LE; McCready DR
    J Surg Oncol; 2009 Mar; 99(4):176-85. PubMed ID: 19065639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Saltman BE; Ganly I; Patel SG; Coit DG; Brady MS; Wong RJ; Boyle JO; Singh B; Shaha AR; Shah JP; Kraus DH
    Head Neck; 2010 Dec; 32(12):1686-92. PubMed ID: 20848412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of patients with intermediate-thickness melanoma.
    Urist MM
    Annu Rev Med; 1996; 47():211-7. PubMed ID: 8712776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
    Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
    N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior gluteal lymph node metastasis of melanoma.
    Fujiwara M; Nagata T; Matsushita Y; Fukamizu H
    J Dermatol; 2013 Oct; 40(10):852-3. PubMed ID: 23962005
    [No Abstract]   [Full Text] [Related]  

  • 32. Sentinel lymph node biopsy and melanoma: 2010 update Part II.
    Stebbins WG; Garibyan L; Sober AJ
    J Am Acad Dermatol; 2010 May; 62(5):737-48;quiz 749-50. PubMed ID: 20398811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy for melanoma--standard of care?
    Otley CC
    Dermatol Surg; 2000 Nov; 26(11):1067-9. PubMed ID: 11096398
    [No Abstract]   [Full Text] [Related]  

  • 34. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sentinel node biopsy between myth and reality].
    Thomas M; Bahmer FA
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):919-21. PubMed ID: 22026359
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in sentinel lymph node mapping for patients with melanoma.
    Brady MS
    Future Oncol; 2012 Feb; 8(2):191-203. PubMed ID: 22335583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
    Essner R
    Expert Rev Anticancer Ther; 2010 May; 10(5):723-8. PubMed ID: 20470004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regarding sentinel node biopsy in the management of melanoma.
    Coldiron B
    Dermatol Surg; 2001 Jan; 27(1):95-7. PubMed ID: 11231262
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous melanoma--retrospective study of a small series of patients.
    Metcalf JS; Hawk JC; Kreutner A
    J S C Med Assoc; 1981 Mar; 77(3):113-7. PubMed ID: 6938740
    [No Abstract]   [Full Text] [Related]  

  • 40. The prognostic significance of nonsentinel lymph node metastasis in melanoma.
    Brown RE; Ross MI; Edwards MJ; Noyes RD; Reintgen DS; Hagendoorn LJ; Stromberg AJ; Martin RC; McMasters KM; Scoggins CR
    Ann Surg Oncol; 2010 Dec; 17(12):3330-5. PubMed ID: 20645010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.